Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Pender & Associates Ltd .
Filed returns
225
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2017 | Pender & Associates Ltd | Health | Emergency medicine training for anaphylaxis/adrenaline medication; biosimilars policy; SPC waiver. (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2017 | Pender & Associates Ltd | Health | Biosimilar policy and national medicines strategy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2017 | Pender & Associates Ltd | Children and Youth Affairs | Childcare policy (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Health | Meeting request (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Taxation | Excise duty policy (Public policy or programme) | 38 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Taxation | Taxation Policy (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Transport | Motor insurance reform (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Health | Introduction of National Medicines Policy, National Medicines Office, and introduction of biosimilars consultation (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Health | Supplementary Protection Certificate Manufacturing Waiver and biosimilars policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Health | Medicines policy and biosimilars (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Taxation | Taxation Policy (Public policy or programme) | 18 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Taxation | Taxation Policy (Matters involving public funds) | 66 | On lobbying.ie |
| May–Aug 2017 | Pender & Associates Ltd | Taxation | Taxation Policy (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Pender & Associates Ltd | Health | Medicines policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Pender & Associates Ltd | Communications | Engagement on broadband policy (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2016 | Pender & Associates Ltd | Health | Engagement on Antimicrobial Resistance policy (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Pender & Associates Ltd | Health | Review/inform national drugs policy, to include additional treatment options (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | Medicines policy (Matters involving public funds) | 2 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | Inform national drugs policy in relation to treatment methods (Legislation) | 4 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | Medicines policy (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | To inform on national drugs policy and the addiction treatment method of Suboxone (Legislation) | 2 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | Medicines policy (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | EU Directive on Medical Technologies (Legislation) | 1 | On lobbying.ie |
| May–Aug 2016 | Pender & Associates Ltd | Health | Engagement on Antimicrobial Resistance policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2015 | Pender & Associates Ltd | Health | Engagement with policy makers to achieve savings/reforms in the Government's/HSE's medicines spending programme (Public policy or programme) | 10 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 87 | 38.7% | |
| Economic Development and Industry | 23 | 10.2% | |
| Justice and Equality | 20 | 8.9% | |
| Taxation | 20 | 8.9% | |
| Children and Youth Affairs | 12 | 5.3% | |
| Communications | 8 | 3.6% | |
| Education and Training | 7 | 3.1% | |
| Banking and Financial Institutions | 6 | 2.7% | |
| Employment | 6 | 2.7% | |
| Food | 6 | 2.7% | |
| Finance | 4 | 1.8% | |
| Housing | 4 | 1.8% | |
| Agriculture | 3 | 1.3% | |
| Community | 3 | 1.3% | |
| Environment | 3 | 1.3% | |
| Public Expenditure and Reform | 3 | 1.3% | |
| Transport | 3 | 1.3% | |
| Trade | 2 | 0.9% | |
| Budgetary matters | 1 | 0.4% | |
| EU Affairs | 1 | 0.4% | |
| Energy and Natural Resources | 1 | 0.4% | |
| Sports and Recreation | 1 | 0.4% | |
| Tourism | 1 | 0.4% |